FIELD: medicine.
SUBSTANCE: invention concerns method of pain relief by introduction of pharmaceutical composition containing effective amount of α-adrenergic antagonist and pharmaceutical composition, containing effective amount of the selective α-2A-antagonist.
EFFECT: method provides prolonged relief of chronic pain.
104 cl, 12 dwg, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NON-SEDATIVE A-2-AGONIST 1-(2,3-DIMETHYL-PHENYL)-ETHYL-1,3-DIHYDRO-IMIDASOLE-2-THIONE | 2004 |
|
RU2345987C2 |
| AGONISTS OF ALPHA-2B OR 2B/2C ADRENORECEPTORS FOR NEURODEGENERATIVE DISEASES TREATMENT | 2003 |
|
RU2330649C2 |
| ENANTIOMERICALLY PURE OPIOID DIARYLMETHYL PIPERAZINE AND METHODS FOR USES THEREOF | 2002 |
|
RU2309153C2 |
| METHOD OF ACTIVATION OF REGULATORY T-CELLS OF ALPHA-2B ADRENERGIC RECEPTOR AGONISTS | 2011 |
|
RU2599495C2 |
| INJECTED COMBINATION OF AGONISTS OF ADRENERGIC RECEPTORS WITH FILLERS FOR REDUCTION OF SKIN RESPONSES TO INJECTION | 2010 |
|
RU2530604C2 |
| (BICYCLOHETEROARYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS AS AGONISTS OF ADRENERGIC RECEPTORS | 2008 |
|
RU2472788C9 |
| (R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
| ANESTHETIC COMPOSITION COMPRISING NMDA-ANTAGONIST AND ALPHA-2-ADRENERGIC AGONIST | 2000 |
|
RU2244558C2 |
| NMDA RECEPTOR MODULATORS AND USING THEM | 2009 |
|
RU2515615C2 |
| MODULATOR OF NMDA-RECEPTOR WITH STABILISED SECONDARY STRUCTURE AND ITS USAGE | 2011 |
|
RU2566821C2 |
